GlassScriptPhysician profile
Sean Patrick Hogan
NPI 1477059574
$73,899.83
in general payments reported to CMS, 2019-2025
10 companies · $1,127 in 2025
The $1,127 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,379 · 2021: $2,400 · 2022: $5,456 · 2023: $25K · 2024: $35K · 2025: $1,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $47K · Travel and Lodging: $6,147 · Food and Beverage: $3,953 · Education: $3,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $46,666.66 |
| Travel and Lodging | $6,146.62 |
| Food and Beverage | $3,953.03 |
| Education | $3,899.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $23,642.54 | 2023-2024 | Biobrace 23mm |
| Arthrex, INC. | $21,119.74 | 2023-2024 | |
| Pylant Medical | $12,827.32 | 2019-2023 | |
| Smith+Nephew, INC. | $8,225.88 | 2023-2024 | Q-Fix, Spatial Frame, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $7,806.67 | 2022-2025 | Mako, Iconix, Tornier Perform Reversed Glenoid |
| Next Science LLC | $148.22 | 2025 | Blastx, Xperience |
| Ossur Americas, INC. | $63.91 | 2024 | Miami J |
| Solventum Corporation | $27.30 | 2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Vericel Corporation | $19.56 | 2024 | Maci |
| Alon Medical Technology | $18.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.